Diseases (AASLD) also presented and continued to revise their clinical practice guidelines,
and the latest updates were in 2015, 2017, and 2018. However, since the medical …

Chronic hepatitis B virus (HBV) infection is a major global health problem. It can cause
progressive liver fibrosis leading to cirrhosis with end-stage liver disease, and a markedly …

Background & Aims Nucleo (s) tide analogue (NUC) withdrawal may result in HBsAg
clearance in a subset of patients. However, predictors of HBsAg loss after NUC withdrawal …

Hepatitis B virus (HBV) infection and nonalcoholic fatty liver disease (NAFLD) are two major
causes of chronic liver disease (CLD) that can cause liver cirrhosis and hepatocellular …

Background & Aims We examined the long-term incidence of hepatocellular carcinoma
(HCC) and hepatic decompensation among chronic hepatitis B (CHB) patients who have …

SGLT2i reduces risk of develo** HCC in patients with co-ex... : Hepatology SGLT2i reduces
risk of develo** HCC in patients with co-existing type 2 diabetes and hepatitis B infection: A …

Despite the availability of an effective hepatitis B virus (HBV) vaccine and universal
immunization schedules, HBV has remained a health problem in various stages such as …

Background: Routinely collected health data are increasingly used in clinical research. No
study has systematically reviewed the temporal trends in the number of publications and …

In the era of antiviral therapy, the main goal of treatment has shifted from the persistent
inhibition of hepatitis B virus (HBV) replication to the pursuit of serological clearance of HBs …

The management of hepatitis B virus (HBV) infection now involves regular and appropriate
monitoring of viral activity, disease progression, and treatment response. Traditional HBV …